Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$17.12 USD
-1.35 (-7.31%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $17.13 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Earnings News For RCKT
-
Rocket Pharmaceuticals (RCKT) Down 10.6% Since Last Earnings Report: Can It Rebound?
-
Rocket Pharmaceuticals: Q2 Earnings Snapshot
-
Rocket Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
-
Why Is Rocket Pharmaceuticals (RCKT) Down 4.8% Since Last Earnings Report?
-
Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil
-
Rocket Pharmaceuticals: Q1 Earnings Snapshot
-
Rocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Progress
-
Why Is Rocket Pharmaceuticals (RCKT) Down 13.6% Since Last Earnings Report?
-
Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4
-
Rocket Pharmaceuticals: Q4 Earnings Snapshot
-
Rocket Pharmaceuticals: Q4 Earnings Snapshot
-
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Progress
-
Rocket Pharmaceuticals: Q3 Earnings Snapshot
-
Rocket Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Progress
-
Rocket Pharmaceuticals: Q2 Earnings Snapshot
-
Rocket Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
-
Rocket Pharmaceuticals: Q1 Earnings Snapshot
-
Rocket Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Progress
-
Rocket Pharmaceuticals: Q4 Earnings Snapshot
-
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial and Operational Results
-
Rocket Pharmaceuticals: Q3 Earnings Snapshot
-
Rocket Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
-
Rocket Pharmaceuticals: Q2 Earnings Snapshot
-
Rocket Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Progress